BRAIN Graphic
Investors

BRAIN is a key player in the bio-based economy

BRAIN AG ranks among the technologically leading companies in Europe in the bioeconomy area, and operates in industrial – so-called white – biotechnology with its key technologies.

BRAIN identifies previously untapped high-performing enzymes, microbial producer organisms and natural compounds derived from complex biological systems to transform them into industrially usable applications. Innovative solutions and products developed from this Toolbox of Nature are successfully deployed in the chemicals sector, as well as in the cosmetics and food manufacturing industries. As part of its growth-oriented industrialization strategy, B.R.A.I.N. Biotechnology Research and Information Network AG (BRAIN AG; ISIN DE0005203947 / WKN 520394) has been the first bioeconomy company to be listed in the Prime Standard of the Frankfurt Stock Exchange since February 2016.

Forum

Deutsches Eigenkapitalforum (German Equity Forum)

Meet BRAIN CEO Jürgen Eck and CFO Manfred Bender in Frankfurt from 25 to 27 November 2019.

Register here

Selected publications and financial events

Financial Publication

Quarterly Statement as of 30 June 2019

Download PDF
Presentation

Corporate presentation 2018/19

BRAIN AG, August 30, 2019

Download PDF
Next Financial Event

Publication of the annual report as at 30.09.2019 (12M)

14 January 2020
Financial Calendar

Recent financial news

Corporate News, 30 August 2019

BRAIN AG shares strong nine-month figures demonstrating growth in all areas

Show news
Corporate News, 25 June 2019

BRAIN AG sells its entire stake in Monteil Cosmetics International GmbH

Show news
Corporate News, 29 May 2019

BRAIN AG achieves significant growth in the first half of the 2018/19 financial year

Show news

Good reasons to invest in BRAIN

Megatrend trailblazer

BRAIN is widely recognized as a trailblazer for the transformation of a mineral oil-based economy towards sustainable industrial production based on industrial biotechnology. The fast-growing bioeconomy is a megatrend of the 21st century.

Bioeconomy
High-tech disruptor

BRAIN applies a world-class biotechnology portfolio to its proprietary BioArchive. Research and development acitivties are driven by a solution-focused mindset which overcomes the limitations of the single technology approach that other players in the field of biotechnology are confronted with.

Solutions
Diverse range of applications

Based on nature’s biodiversity BRAIN focuses on three product categories only, but they cover highly differing industrial applications ranging from healthier food to sustainable green mining without depending on any single market.

Products & Markets
Reliable partner

BRAIN supports its customers in their endeavors to differentiate themselves from competitors, understanding that the key to successful business is the right partnership model. BRAIN looks back on more than 100 successful joint R&D projects with major international companies.

R&D partnership and cooperation
Global provider

BRAIN Group companies are leaders in their fields and unite first-class R&D, production expertise and access to attractive markets under one roof. All BRAIN Group companies act as interconnected entities addressing specific B2B markets and industrial partners.

BRAIN Group

Investor Relations service

You want to invest in BRAIN or have questions? We are here for you. Please get in touch with us.

Investor Relations Contact

Share this page